| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/12/2001 | EP1131354A1 Contraceptive antibody vaccines |
| 09/12/2001 | EP1131342A1 Compositions and methods for controlling plant pests |
| 09/12/2001 | EP1131106A1 Compositions and methods for producing vascular occlusion |
| 09/12/2001 | EP1131090A2 Method of using pon-1 to decrease atheroma formation |
| 09/12/2001 | EP1131085A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 09/12/2001 | EP1131080A2 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
| 09/12/2001 | EP1131039A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 09/12/2001 | EP0956028B1 Submucosal tissue inhibition of neoplastic cell growth |
| 09/12/2001 | EP0813427B1 Platelet glue wound sealant |
| 09/12/2001 | EP0732916B1 Viracidal, bactericidal and spermicidal vaginal suppository |
| 09/12/2001 | EP0666751B1 Mutants of hepatitis a virus strain hm-175 for use as hepatitis a vaccines |
| 09/12/2001 | EP0637249B1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides |
| 09/12/2001 | CN1312817A Dolastatin 15 derivatives |
| 09/12/2001 | CN1312725A Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/12/2001 | CN1312704A Incorporation of exogenous lact'c bacteria into oral microflora |
| 09/12/2001 | CN1312292A Preparation process of gene antibiotic peptide medicine from transgenic antibiotic peptide fly maggot |
| 09/12/2001 | CN1312110A Chinese medicine preparation for treating infant pulmonitis and dyspneic cough |
| 09/12/2001 | CN1312101A Vital energy benefitting menthol powder as one Chinese medicine preparation for treating gastrosis |
| 09/12/2001 | CN1312098A Medicated wine for treating rheumatism, rheumatoid disease and other arthralgia |
| 09/12/2001 | CN1312095A Hypertension-treating medicine |
| 09/12/2001 | CN1312094A Medicine for treating heart disease and promoting recovery |
| 09/12/2001 | CN1312092A Rheumatism treating oral capsule and plaster and their preparation method |
| 09/12/2001 | CN1312091A Vaginitis treating medicine |
| 09/12/2001 | CN1312090A Chinese medicine for promoting height and intelligence growth |
| 09/12/2001 | CN1312087A Medicine for treating neurosis via head acupoint osmosis |
| 09/12/2001 | CN1312082A Leukoderma curing plaster |
| 09/12/2001 | CN1312081A Wart and mole eliminating agent |
| 09/12/2001 | CN1070709C Traditional Chinese medicinal preparation for treating hepatopathy and preparation method thereof |
| 09/12/2001 | CN1070708C Medicine for regrowing of muscle around exposed bone and preparing method thereof |
| 09/12/2001 | CN1070707C Chinese medicinal preparation for treating Aids and its preparing method thereof |
| 09/12/2001 | CN1070706C Process for producing moxas |
| 09/11/2001 | US6288087 An extract from eupatorium purpurem, cytochrome p450 inducing compound, sugar, a source of phosphate, and one or more carriers |
| 09/11/2001 | US6288035 Administering polypeptide as antitumor agent to treat melanoma; medical diagnosis |
| 09/11/2001 | US6288032 Polypeptides for osteoporosis and other bone disorder treatment |
| 09/11/2001 | US6288027 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 09/11/2001 | US6287836 Histidine kinase from Streptococcus pneumoniae and compositions therecontaining |
| 09/11/2001 | US6287802 EXT2 gene |
| 09/11/2001 | US6287757 Amino acid-trehalose composition |
| 09/11/2001 | US6287576 Biostimulating agent |
| 09/11/2001 | US6287557 Methods of gene therapy using herpes viral vectors expressing GM-CSF |
| 09/11/2001 | CA2176205C Osteogenic product and process |
| 09/11/2001 | CA2164866C Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 09/07/2001 | WO2001064874A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 09/07/2001 | WO2001064870A2 Mutated cyclin g1 protein |
| 09/07/2001 | WO2001064847A2 In vitro modification of cardiac valvular xenografts |
| 09/07/2001 | WO2001064756A1 Salmon-origin chondroitin sulfate |
| 09/07/2001 | WO2001064750A2 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | WO2001064739A1 Tcf responsive element |
| 09/07/2001 | WO2001064258A1 Agent for the treatment of wounds |
| 09/07/2001 | WO2001064240A2 Methods for promoting production of myelin by schwann cells |
| 09/07/2001 | WO2001064228A1 Method for producing a bioactive substance from blood serum |
| 09/07/2001 | WO2001064227A2 Androgenic activity of eucommia ulmoides extracts |
| 09/07/2001 | WO2001064046A2 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof |
| 09/07/2001 | WO2001032898A3 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 09/07/2001 | WO2001021761A3 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 09/07/2001 | WO2000078119A3 Cardiomyocytes with enhanced proliferative potential |
| 09/07/2001 | WO2000076528A3 Pharmaceutical preparation containing proteins |
| 09/07/2001 | CA2401869A1 Agent for the treatment of wounds |
| 09/07/2001 | CA2401716A1 Methods for promoting production of myelin by schwann cells |
| 09/07/2001 | CA2401704A1 Salmon-origin chondroitin sulfate |
| 09/07/2001 | CA2401621A1 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | CA2401533A1 Tcf responsive element |
| 09/06/2001 | US20010019841 Medium and matrix for long-term proliferation of cells |
| 09/06/2001 | US20010019819 Freeze drying platelets |
| 09/06/2001 | DE10035735A1 Composition preventing hair loss contains a combination of biotin or caffeine as effective ingredient together with a 10-18C fatty acid or salt |
| 09/06/2001 | DE10009341A1 Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten A method for antigen-specific stimulation of T lymphocytes |
| 09/06/2001 | DE10006889A1 Verwendung von Inhibitoren von Caspase-3 oder der Caspase-aktivierten Desoxyribonuclease (CAD) zur Behandlung von Herzerkrankungen Use of inhibitors of caspase-3 or caspase-activated deoxyribonuclease (CAD) for the treatment of heart disease |
| 09/05/2001 | EP1130394A1 In vitro models of CNS function and dysfunction |
| 09/05/2001 | EP1130088A1 Hybrid cell vaccines |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1129728A1 Methods and compositions for the selective modification of nucleic acids |
| 09/05/2001 | EP1129717A1 Use of homologues of staphylococcal enterotoxins for cancer treatment |
| 09/05/2001 | EP1129208A1 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 09/05/2001 | EP1129205A1 Transfection of male germ cells for generation of selectable transgenic stem cells |
| 09/05/2001 | EP1129204A1 Novel system for regulating transgene expression |
| 09/05/2001 | EP1129196A2 Virulence genes and proteins, and their use |
| 09/05/2001 | EP1129183A2 Human glycine transporter type 2 |
| 09/05/2001 | EP1129177A1 Avipox vector coding an hiv antigen and a cytokine |
| 09/05/2001 | EP1129176A1 Embryonic stem cells |
| 09/05/2001 | EP1129175A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 09/05/2001 | EP1128837A2 Method for preventing and reversing atherosclerosis in mammals |
| 09/05/2001 | EP1128836A2 In utero transplantation of human mesenchymal stem cells |
| 09/05/2001 | EP1128731A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 09/05/2001 | EP0642326B1 Non-fibrogenic, alginate-coated transplants, process of manufacture and method of use thereof |
| 09/05/2001 | CN1311822A Gene therapy method |
| 09/05/2001 | CN1311031A Chinese kerbal medicine preparation for curing urinaemia |
| 09/05/2001 | CN1311030A Chinese herbal medicine composition for smoothing the liver and detoxication |
| 09/05/2001 | CN1311028A Medicine for curing asthma, chronic acid acute bronchitis and pulmonary emphysema |
| 09/05/2001 | CN1311027A Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation |
| 09/05/2001 | CN1311026A Medicine for curing lupus erythematosus brain disease |
| 09/05/2001 | CN1311025A Medicine for curing lupus erythematosus etc. immune diseases induced diseases |
| 09/05/2001 | CN1311020A Medicine for curing tuberculosis and preparing method |
| 09/05/2001 | CN1311019A External use medicine for curing sexual disorder for male |
| 09/05/2001 | CN1311018A Chinese herbal plaster for anti-cancer and analgesic |
| 09/05/2001 | CN1311007A Decoction of medicinal ingredients for curing enterogastric diseases |
| 09/05/2001 | CN1311004A Oral liquor for tonifying the brain and replenishing wisdom |
| 09/05/2001 | CN1311003A Pearl compositions and its prepn. method |
| 09/05/2001 | CN1311002A Refined bear gall powder and its preparing method |
| 09/05/2001 | CN1310960A Producing natural agent from wood frog oviduct and formula for emulsified oil |
| 09/05/2001 | CN1070497C Completely dissolved bone tissue and method for producing same |